Soroush Mana Pharmed is a privately held, knowledge-based subsidiary of Golrang Pharmaceutical Investment Co. Established in 2011 under the name Hasti Aria Shimi, the company initially focused on research and development, as well as the manufacturing of active pharmaceutical ingredients (APIs), particularly in the field of narcotic drugs.
Through numerous achievements in R&D, API synthesis, production, and the establishment of advanced factories and production lines, the company strengthened its scientific and operational foundation. In 2018, it rebranded as Soroush Mana Pharmed and expanded its operations to include various functional units, such as research and development, API synthesis, production, technical and engineering, quality control, quality assurance, regulatory affairs, trading, sales, human resources, accounting and finance, commercial operations, business development, and storage facilities.